Pemirolast in Allergen Challenge (PEMAG)

计划入组 1 人 · 首次发布于 2017 年 4 月 19 日

PH 2 Pemigatinib in SDH-deficient GIST

计划入组 24 人 · 首次发布于 2026 年 2 月 27 日

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

计划入组 790 人 · 首次发布于 2023 年 9 月 15 日

Pemigatinib(Pemazyre)

C₂₄H₂₇F₂N₅O₄ · Rx

pemivibart

Pemirolast

C₁₀H₈N₆O · Rx

PERI-SWAB, LLC

United States

Pedi-Stat, Inc.

United States

PERI HEALTH PTE. LTD.

Singapore

Pemi Launches Women's Daily Supplement Routine Built Specifically for Perimenopause

Pemivibart Guidelines Updated for COVID-19 Preexposure Prophylaxis in Immunocompromised Patients

Invivyd's Pemgarda Shows Continued Neutralizing Activity Against SARS-CoV-2 Variant XEC